
Orchestra BioMed Holdings, Inc.: shareholders and insiders
Price
$7.17
November 19, 2026Market cap $564M
What Ploutos Investor adds for Orchestra BioMed
Part of Ploutos Investor, €9.99 a month
- The full history: 4 fiscal years, from 2022
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has risen 30% since Nov 10, 2026, when the 10-Q these figures come from was filed ($5.73 then, $7.46 on Nov 18, 2026). The figures date from before that move.10-Q
Insiders and their shares
Purchases and sales by officers and directors, from their own Form 4 filings.
Reading the newest filings from the SEC. This part fills in on its own in a few seconds.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Medtronic plcwith 1 more personShare of class17.8%
- RTW Investments, LPwith 1 more personShare of class16.2%
- Perceptive Advisors LLCwith 2 more personsShare of class9.99%
- Tasso Partners, LLCwith 1 more personShare of class5.50%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Medtronic plcwith 1 more person | 17.8% | 10.08M | Feb 27, 20262 filings since Feb 14, 2025 | 13G/A | |
| RTW Investments, LPwith 1 more person | 16.2% | 13.14M | Nov 12, 20265 filings since May 1, 2025 | 13D/A | |
| Perceptive Advisors LLCwith 2 more persons | 9.99% | 5.68M | Nov 14, 2025 | 13G/A | |
| Tasso Partners, LLCwith 1 more person | 5.50% | 3.10M | Nov 19, 2025 | 13G |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
RTW Investments, LP16.2%From the filing of Feb 25, 2026
Item 4 of the Schedule 13D is hereby amended and supplemented as follows: On February 23, 2026, the RTW Funds submitted notices to the Issuer increasing the Maximum Percentage under the Pre-Funded Warrants from 9.99% to 19.99%. In accordance with the terms of the Pre-Funded Warrants, this increase in the Maximum Percentage will become effective on the 61st day following the delivery of the notice. As a result of the increase in the Maximum Percentage, the Reporting Persons are deemed, effective February 24, 2026, to beneficially own all of the shares underlying the Pre-Funded Warrants, resulting in an increase in the Reporting Persons' aggregate beneficial ownership by 3,636,363 shares of…
From the filing of Feb 25, 2026
Fell to 5% or less (1)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- BlackRock, Inc.3.70%Apr 29, 202513G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Citadel Advisors (Griffin)In the quarter-57%
- Renaissance TechnologiesIn the quarter-87%
- AQR CapitalIn the quarter
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Citadel Advisors (Griffin) | 24.2K | -57% | $200.0K | 0.00% |
| Renaissance Technologies | 11.5K | -87% | $100.0K | 0.00% |
| AQR Capital | 11.8K | $100.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 3.24% of its shares outstanding were held short, +0.2% since the report before.
- Shares held short
- 2.55M
- 3.24%
- Since the report before2.55M on Sep 30, 2026
- +0.2%
- 9.7
- 263.1K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 90%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 1.28M
- Nov 15, 2023: Shares held short 1.30M
- Nov 30, 2023: Shares held short 1.13M
- Dec 15, 2023: Shares held short 1.19M
- Dec 29, 2023: Shares held short 1.12M
- Jan 12, 2024: Shares held short 976.1K
- Jan 31, 2024: Shares held short 1.05M
- Feb 15, 2024: Shares held short 987.1K
- Feb 29, 2024: Shares held short 901.0K
- Mar 15, 2024: Shares held short 876.4K
- Mar 28, 2024: Shares held short 858.0K
- Apr 15, 2024: Shares held short 833.3K
- Apr 30, 2024: Shares held short 856.3K
- May 15, 2024: Shares held short 833.6K
- May 31, 2024: Shares held short 763.1K
- Jun 14, 2024: Shares held short 767.6K
- Jun 28, 2024: Shares held short 821.0K
- Jul 15, 2024: Shares held short 1.02M
- Jul 31, 2024: Shares held short 963.6K
- Aug 15, 2024: Shares held short 1.06M
- Aug 30, 2024: Shares held short 1.02M
- Sep 13, 2024: Shares held short 989.0K
- Sep 30, 2024: Shares held short 911.9K
- Oct 15, 2024: Shares held short 826.1K
- Oct 31, 2024: Shares held short 778.6K
- Nov 15, 2024: Shares held short 754.3K
- Nov 29, 2024: Shares held short 769.7K
- Dec 13, 2024: Shares held short 703.2K
- Dec 31, 2024: Shares held short 703.9K
- Jan 15, 2025: Shares held short 736.7K
- Jan 31, 2025: Shares held short 474.0K
- Feb 14, 2025: Shares held short 480.9K
- Feb 28, 2025: Shares held short 524.8K
- Mar 14, 2025: Shares held short 546.2K
- Mar 31, 2025: Shares held short 572.3K
- Apr 15, 2025: Shares held short 541.4K
- Apr 30, 2025: Shares held short 1.23M
- May 15, 2025: Shares held short 1.19M
- May 30, 2025: Shares held short 1.21M
- Jun 13, 2025: Shares held short 1.06M
- Jun 30, 2025: Shares held short 509.0K
- Jul 15, 2025: Shares held short 558.8K
- Jul 31, 2025: Shares held short 506.6K
- Aug 15, 2025: Shares held short 564.1K
- Aug 29, 2025: Shares held short 774.2K
- Sep 15, 2025: Shares held short 736.7K
- Sep 30, 2025: Shares held short 746.3K
- Oct 15, 2025: Shares held short 743.5K
- Oct 31, 2025: Shares held short 989.7K
- Nov 14, 2025: Shares held short 964.4K
- Nov 28, 2025: Shares held short 774.3K
- Dec 15, 2025: Shares held short 677.7K
- Dec 31, 2025: Shares held short 737.1K
- Jan 15, 2026: Shares held short 787.2K
- Jan 30, 2026: Shares held short 826.1K
- Feb 13, 2026: Shares held short 759.8K
- Feb 27, 2026: Shares held short 797.1K
- Mar 13, 2026: Shares held short 794.5K
- Mar 31, 2026: Shares held short 957.9K
- Apr 15, 2026: Shares held short 886.6K
- Apr 30, 2026: Shares held short 972.6K
- May 15, 2026: Shares held short 842.3K
- May 29, 2026: Shares held short 948.2K
- Jun 15, 2026: Shares held short 1.24M
- Jun 30, 2026: Shares held short 2.22M
- Jul 15, 2026: Shares held short 2.59M
- Jul 31, 2026: Shares held short 2.43M
- Aug 14, 2026: Shares held short 2.38M
- Aug 31, 2026: Shares held short 2.46M
- Sep 15, 2026: Shares held short 2.37M
- Sep 30, 2026: Shares held short 2.55M
- Oct 15, 2026: Shares held short 2.55M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading46.3% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 46.3% of the shares in the reported trades were short sales, against 52.0% in the 14 before.
- Last 14 sessionsOct 30, 2026 – Nov 18, 2026
- 46.3%
- The 14 beforeOct 12, 2026 – Oct 29, 2026
- 52.0%
- Change
- -5.7 pts
- Short sales a dayon average, of 269.3K shares
- 124.6K
- More than atof 3,656 US-listed companies, same days
- 36%
- Median of alleight in ten from 34.4% to 63.7%
- 50.3%
- Short sales
- Oct 12, 2026: Short sales 50.6%
- Oct 13, 2026: Short sales 53.3%
- Oct 14, 2026: Short sales 50.8%
- Oct 15, 2026: Short sales 52.1%
- Oct 16, 2026: Short sales 32.3%
- Oct 19, 2026: Short sales 72.5%
- Oct 20, 2026: Short sales 37.6%
- Oct 21, 2026: Short sales 73.9%
- Oct 22, 2026: Short sales 69.6%
- Oct 23, 2026: Short sales 82.5%
- Oct 26, 2026: Short sales 67.3%
- Oct 27, 2026: Short sales 46.8%
- Oct 28, 2026: Short sales 40.6%
- Oct 29, 2026: Short sales 62.4%
- Oct 30, 2026: Short sales 75.8%
- Nov 2, 2026: Short sales 89.3%
- Nov 3, 2026: Short sales 61.4%
- Nov 4, 2026: Short sales 41.7%
- Nov 5, 2026: Short sales 69.5%
- Nov 6, 2026: Short sales 27.4%
- Nov 9, 2026: Short sales 50%
- Nov 10, 2026: Short sales 75.3%
- Nov 11, 2026: Short sales 38.4%
- Nov 12, 2026: Short sales 48%
- Nov 13, 2026: Short sales 43.7%
- Nov 16, 2026: Short sales 38.1%
- Nov 17, 2026: Short sales 34.2%
- Nov 18, 2026: Short sales 48.6%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.04%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.01%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.01%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.00%
- IWMiShares Russell 2000 ETFWeight in the fund0.00%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- SCHBSchwab U.S. Broad Market ETFWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
8 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 52
- Q4 2025: Managers 63
- Q1 2026: Managers 66
- Q2 2026: Managers 77
Institutional investors by quarter
The fund managers holding OBIO, quarter by quarter, from Q4 2022 to Q2 2025, 11 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 77 managers held 27.69M shares, worth $119M. During the quarter 24 opened a position, 14 closed one, 22 added and 14 trimmed.
The largest holders, Q2 2026
- Rtw InvestmentsIn the quarter+15%
- Perceptive AdvisorsIn the quarter
- BlackRockIn the quarter+295%
- Vanguard Capital ManagementIn the quarter-8.2%
- Geode Capital ManagementIn the quarter+108%
- Alyeska Investment GroupIn the quarter
- Propel Bio ManagementIn the quarter
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICASIn the quarter
- State StreetIn the quarter+205%
- Rice Hall James & AssociatesIn the quarter×22.3
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Rtw Investments | 9.56M | +15% | $41M |
| Perceptive Advisors | 5.04M | $22M | |
| BlackRock | 2.51M | +295% | $11M |
| Vanguard Capital Management | 2.02M | -8.2% | $8.7M |
| Geode Capital Management | 1.01M | +108% | $4.4M |
| Alyeska Investment Group | 1.00M | $4.3M | |
| Propel Bio Management | 896.7K | $3.9M | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS | 642.2K | $2.8M | |
| State Street | 516.1K | +205% | $2.2M |
| Rice Hall James & Associates | 424.0K | ×22.3 | $1.8M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Orchestra BioMed's filings show?
Who buys and sells is one part of Orchestra BioMed's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Which well-known managers hold OBIO?
3 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $200.0K.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.